Lingjian Kong

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Second Affiliated Hospital of Harbin Medical University(Current)

Lingjian Kong is an author at Second Affiliated Hospital of Harbin Medical University specializing in alcoholic liver disease progression, gut microbiome, and microbiome research.

Publications per year

2021–2021

Publications

Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance

Lingjian Kong, Jing Chen, Xiaoli Ji et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 78 citations · Full text

Life Sciences, Bioinformatics, Molecular Medicine +17

1–1 of 1